Clinical trial
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir…
NCT00002239 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00002239 |
|---|---|
| Title | A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults |
| Official title | A Controlled Phase 2 Trial Assessing Three Doses of T-20 in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-1 Infected Adults |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Trimeris Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Enfuvirtide, Ritonavir, Abacavir sulfate, Amprenavir, Efavirenz |
| Enrollment | 68 |
| Start date | May 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 15, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: